Australia consults on new codeine options

15 December 2015 - Deborah Wilkes

Archived

Australia's Therapeutic Goods Administration (TGA) is consulting on a broader range of options for codeine-containing medicines. The move comes soon after the regulatory agency deferred a decision on its proposed reverse-switch of all non-prescription medicines containing codeine to prescription status.

Click tags below for more information on topics:

TGA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: